USP22 and colorectal cancer: In colorectal cancer, USP22 expression was negatively correlated with tumor purity, which was an indicator of prognosis,[35] as determined by analyzing the ratio of stromal and infiltrated immune cells (r = −0.14, p = 4.55×10−3, Spearman) (Figure 7F).